19)

Documents about 19)

• COVID-19 Reactogenicity#162544ClinicalTrials.gov
• UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)#123555ClinicalTrials.gov
• COVID-19 Vaccine Messaging, Part 1#148592ClinicalTrials.gov
• Discussing COVID-19 Vaccines in Private Facebook Groups#141067ClinicalTrials.gov
• The Nitazoxanide Plus Atazanavir for COVID-19 Study#162552ClinicalTrials.gov
• COVID-19 Fourth Dose Study in Australia#162564ClinicalTrials.gov
• A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults#28433ClinicalTrials.gov
• A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals#141095ClinicalTrials.gov
• Immunogenicity of an Inactivated COVID-19 Vaccine#28440ClinicalTrials.gov
• Clinical Study of Tanshinone Capsules Against COVID-19#123504ClinicalTrials.gov
• CONFIDENT: Supporting Long-term Care Workers During COVID-19#127700ClinicalTrials.gov
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)#148582ClinicalTrials.gov
• Covid-19 Patients With Hypertension and/or Kidney Diseases#28478ClinicalTrials.gov
• COVID-19 Follow up Intensive Care Studies#143780ClinicalTrials.gov
• Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults#154736ClinicalTrials.gov
• COVID-19-Hospitalisierungen in Deutschland#11934DataCite
• COVID-19-Hospitalisierungen in Deutschland#13348DataCite
• COVID-19-Hospitalisierungen in Deutschland#14622DataCite
• COVID-19-Hospitalisierungen in Deutschland#20803DataCite
• COVID-19-Hospitalisierungen in Deutschland#120836DataCite
• Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)#123549ClinicalTrials.gov
• The Impact of COVID-19 on Maternal and Neonatal Outcomes#146257ClinicalTrials.gov
• Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers#146280ClinicalTrials.gov
• Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations#152492ClinicalTrials.gov
• Local Thermotherapy for Patients With Mild-to-moderate COVID-19#158059ClinicalTrials.gov
• The effectiveness of COVID-19 vaccines and the added benefit of booster doses in Hessen, Germany, during the COVID-19 pandemic: Results from a vaccinated-only study.#9904PubMed
• A Study of Ad26.COV2.S in Adults (COVID-19)#67696ClinicalTrials.gov
• Consensus, Convergence, and Covid-19: The Role of Religion in Leaders’ Responses to Covid-19#107000PhilArchive
• COVID-19-Todesfälle in Deutschland#120830DataCite
• Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection#121455ClinicalTrials.gov
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3)#125924ClinicalTrials.gov
• Is self-report brain fog after mild COVID-19 truly induced by COVID-19 infection? A longitudinal fNIRS study#5338Europe PMC
• ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine#18691ClinicalTrials.gov
• A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)#28431ClinicalTrials.gov
• No fault vaccine injury compensation after COVID-19: A systematic literature review and proposed typology.#9473PubMed
• Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches.#10014PubMed
• Incentives can spur COVID-19 vaccination uptake#17057EconStor
• A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes#136392ClinicalTrials.gov
• COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection#136429ClinicalTrials.gov
• Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers#18695ClinicalTrials.gov
• Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)#28437ClinicalTrials.gov
• Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death#28444ClinicalTrials.gov
• Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents#123547ClinicalTrials.gov
• Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older#143659ClinicalTrials.gov
• A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)#162530ClinicalTrials.gov
• Examining Factors Associated With Covid-19 Disruptions To Tuberculosis Services#167503EliScholar
• Remote and On‐Site Working During the Covid‐19 Pandemic: (Re)Configuring Work Organisation in Border Control Services and the Nuclear Industry#161322HAL (France)
• Transport risks in the supply chains: Post COVID-19 challenges#17209EconStor
• Tracing app technology: an ethical review in the COVID-19 era and directions for post-COVID-19#101297PhilArchive
• A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)#121443ClinicalTrials.gov